LONDON (Alliance News) - Drug discovery and development business Sareum Holdings PLC Thursday said it is not aware of any undisclosed reason for a sharp rise in its share price.
Shares in Sareum were up 24% at 0.670 pence Thursday, having jumped as high as 0.80p earlier in the session.
Last month the company reported a narrowed pretax loss for its first half to end-December as it prepares to move towards becoming a clinical-stage development company, with clinical trials of its CHK1 cancer treatment expected to begin before the end of its current year.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Sareum (SAR)